The journey continues Three retrospective cohort studies on 28 439 post-infarction patients receiving contemporary ‘real world’ therapy tested the effects of n-3 PUFA patients, confirming a highly significant reduction of mortality. 9–11 This also certifies that contemporary treatment does not disqualify the benefits of n-3 PUFA.
1
—
—